VIVAVISION

VIVAVISION was founded in August 2016 as an innovative drug company. Since its establishment, the company has focused on developing internationally leading innovative drugs for the treatment of ophthalmic diseases, committing to providing millions of patients with better and more effective therapeutic options. VIVAVISION boasts a world-class ophthalmology team and has built a cutting-edge product pipeline. Our pipeline product VVN001 is currently in the clinical stage, while other ocular surface and fundus treatment products are at various stages of development. To date, VIVAVISION has become one of the most advanced ophthalmic innovative drug research and development companies in China.